HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $20 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.1%

Neg 0% Neu 87.1% Pos 0%

HC Wainwright & Co. analyst Arthur He reiterates Solid Biosciences (NASDAQ:SLDB) with a Buy and maintains $20 price target.